Clinical Trial Update: Low-Dose Lithium for the Treatment of Behavioral Symptoms in Frontotemporal Dementia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating low-dose lithium for behavioral symptoms in frontotemporal dementia has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frontotemporal Dementia

Drugs mentioned

• Lithium carbonate (Lithium carbonate)

Snippet

Sponsor: Columbia University | Conditions: Frontotemporal Dementia (FTD) | Phase 2 | Status: COMPLETED | Results posted: 2025-02-03